Literature DB >> 22951450

National, state, and local area vaccination coverage among children aged 19-35 months--United States, 2011.

.   

Abstract

High vaccination coverage in children by age 2 years has resulted in historically low levels of most vaccine-preventable diseases in the United States, but coverage must be maintained to reduce the burden of disease further and prevent a resurgence of these diseases, particularly in populations with lower vaccination coverage. This report describes national, state, and selected local area vaccination coverage by age 19-35 months for children born during January 2008-May 2010, based on 2011 National Immunization Survey (NIS) results. Vaccination coverage remained above the national Healthy People 2020 target* of 90% for ≥1 dose measles, mumps, rubella vaccine (MMR) (91.6%), ≥3 doses of hepatitis B vaccine (HepB) (91.1%), ≥3 doses of poliovirus vaccine (93.9%), and ≥1 dose of varicella vaccine (90.8%). For the birth dose of HepB, coverage increased from 64.1% in 2010 to 68.6% in 2011; for the more recently recommended ≥2 doses of hepatitis A vaccine (HepA) and rotavirus vaccines, coverage increased from 49.7% to 52.2% and from 59.2% to 67.3%, respectively; and for the full series of Haemophilus influenzae type b vaccine (Hib), coverage increased from 66.8% to 80.4%, reflecting recovery from the Hib shortage that occurred during December 2007-September 2009. The percentage of children who had not received any vaccinations remained at <1%. Children living below the poverty level had lower coverage than children living at or above poverty for ≥4 doses of diphtheria, tetanus toxoid, and acellular pertussis vaccine (DTaP) and ≥4 doses of pneumococcal conjugate vaccine (PCV) (by 6 percentage points each); the full Hib series (by 8 percentage points); and for rotavirus vaccination (by 10 percentage points). Continued partnerships among national, state, local, private, and public entities are needed to sustain current coverage levels and ensure that coverage for the more recently recommended vaccines continues to increase for all children.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22951450

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  35 in total

Review 1.  Economic evaluation of Varicella vaccination: results of a systematic review.

Authors:  Brigid Unim; Rosella Saulle; Sara Boccalini; Cristina Taddei; Vega Ceccherini; Antonio Boccia; Paolo Bonanni; Giuseppe La Torre
Journal:  Hum Vaccin Immunother       Date:  2013-07-03       Impact factor: 3.452

Review 2.  The rise (and fall?) of parental vaccine hesitancy.

Authors:  Charitha Gowda; Amanda F Dempsey
Journal:  Hum Vaccin Immunother       Date:  2013-06-06       Impact factor: 3.452

3.  The architecture of provider-parent vaccine discussions at health supervision visits.

Authors:  Douglas J Opel; John Heritage; James A Taylor; Rita Mangione-Smith; Halle Showalter Salas; Victoria Devere; Chuan Zhou; Jeffrey D Robinson
Journal:  Pediatrics       Date:  2013-11-04       Impact factor: 7.124

4.  Evaluation of a social marketing campaign to increase awareness of immunizations for urban low-income children.

Authors:  Emmanuel M Ngui; Chelsea Hamilton; Melodee Nugent; Pippa Simpson; Earnestine Willis
Journal:  WMJ       Date:  2015-02

5.  Comparative assessment of immunization coverage of migrant children between national immunization program vaccines and non-national immunization program vaccines in East China.

Authors:  Yu Hu; Shuying Luo; Xuewen Tang; Linqiao Lou; Yaping Chen; Jing Guo
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 6.  Utilizing health information technology to improve vaccine communication and coverage.

Authors:  Melissa S Stockwell; Alexander G Fiks
Journal:  Hum Vaccin Immunother       Date:  2013-06-04       Impact factor: 3.452

7.  The role of ethnicity and travel on Hepatitis A vaccination coverage and disease incidence in Arizona at the United States-Mexico Border.

Authors:  Kacey C Ernst; Laura M Erhart
Journal:  Hum Vaccin Immunother       Date:  2014-03-06       Impact factor: 3.452

8.  Hepatitis A vaccination coverage among adults 18-49 years traveling to a country of high or intermediate endemicity, United States.

Authors:  Peng-Jun Lu; Kathy K Byrd; Trudy V Murphy
Journal:  Vaccine       Date:  2013-03-21       Impact factor: 3.641

9.  Children and Adolescents Unvaccinated Against Measles: Geographic Clustering, Parents' Beliefs, and Missed Opportunities.

Authors:  Philip J Smith; Edgar K Marcuse; Jane F Seward; Zhen Zhao; Walter A Orenstein
Journal:  Public Health Rep       Date:  2015 Sep-Oct       Impact factor: 2.792

10.  Targeting pediatric versus elderly populations for norovirus vaccines: a model-based analysis of mass vaccination options.

Authors:  Molly K Steele; Justin V Remais; Manoj Gambhir; John W Glasser; Andreas Handel; Umesh D Parashar; Benjamin A Lopman
Journal:  Epidemics       Date:  2016-10-24       Impact factor: 4.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.